Grandview Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.78M Sell
1,538
-438
-22% -$517K 0.49% 35
2026
Q2
$2.39M Buy
1,976
+169
+9% +$173K 0.59% 37
2026
Q1
$1.66M Buy
1,807
+256
+17% +$260K 0.49% 45
2025
Q4
$1.67M Buy
1,551
+108
+7% +$103K 0.46% 44
2025
Q3
$1.1M Buy
1,443
+26
+2% +$19.3K 0.31% 50
2025
Q2
$1.1M Buy
1,417
+46
+3% +$35.7K 0.35% 48
2025
Q1
$1.13M Buy
1,371
+208
+18% +$173K 0.43% 45
2024
Q4
$898K Buy
+1,163
New +$963K 0.33% 52
2024
Q2
– Sell
-763
Closed -$593K – 77
2024
Q1
$593K Buy
763
+227
+42% +$162K 0.27% 64
2023
Q4
$312K Buy
+536
New +$313K 0.16% 81
2021
Q2
– Sell
-154
Closed -$29K – 295
2021
Q1
$29K Buy
+154
New +$30.1K 0.02% 249

Other funds holding LLY

Grandview Asset Management's LLY Position: Q3 2026 in Review

Grandview Asset Management reduced its Eli Lilly (LLY) stake by 22% in Q3 2026, selling an estimated $517K and leaving 1,538 shares worth $1.78M. The position accounts for 0.49% of the portfolio, ranked #35.

Grandview Asset Management first reported a position in LLY in Q1 2021 and has held it in 11 quarters since. The position peaked at $2.39M in Q2 2026. 4,626 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Grandview Asset Management held 1,538 shares of Eli Lilly worth $1.78M as of Q3 2026.
  • Grandview Asset Management sold 438 Eli Lilly shares in Q3 2026, an estimated $517K.
  • Eli Lilly made up 0.49% of Grandview Asset Management's portfolio in Q3 2026, its #35 holding.
  • Grandview Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 11 quarters since.
  • Grandview Asset Management's Eli Lilly position peaked at $2.39M in Q2 2026.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Grandview Asset Management's 13F filing for Q3 2026, filed 19 Oct 2026.